Research shows that women with diet-controlled gestational diabetes have higher inflammation markers during pregnancy and after delivery compared to women without gestational diabetes. According to Gram Research analysis of 366 pregnant women, inflammation markers were 20% higher after delivery and 12% higher right before delivery in the gestational diabetes group. These routine blood markers may help doctors better understand gestational diabetes, though more research is needed to determine if they predict health outcomes.
Researchers tracked blood inflammation markers in 366 pregnant women—170 with diet-controlled gestational diabetes and 196 without—from early pregnancy through after delivery. According to Gram Research analysis, women with gestational diabetes showed different patterns of inflammation throughout pregnancy and especially after giving birth. The study found that certain blood markers were higher in the gestational diabetes group, particularly after delivery. These findings suggest that simple blood tests might help doctors better understand how gestational diabetes affects the body’s inflammation levels, though more research is needed to determine if these markers are useful for clinical care.
Key Statistics
A 2026 cohort study of 366 pregnant women found that women with diet-controlled gestational diabetes had 20% higher postpartum inflammation markers (SIRI) compared to women without gestational diabetes, even after adjusting for age and weight.
Research tracking 170 women with gestational diabetes and 196 without found that inflammation markers measured by platelet-to-lymphocyte ratio were 12% higher immediately before delivery in the gestational diabetes group.
A longitudinal analysis of blood samples from 366 pregnant women showed that all six inflammation markers studied displayed different patterns throughout pregnancy in women with gestational diabetes compared to normoglycemic controls.
According to a 2026 retrospective cohort study of 366 women, the postpartum period showed the most robust differences in inflammation markers between women with diet-controlled gestational diabetes and those without gestational diabetes.
The Quick Take
- What they studied: How blood inflammation markers change throughout pregnancy and after delivery in women with diet-controlled gestational diabetes compared to women without gestational diabetes
- Who participated: 366 pregnant women at a hospital in Beijing: 170 women with gestational diabetes controlled by diet alone, and 196 women with normal blood sugar levels. Women with gestational diabetes tended to be older and heavier at the start of pregnancy
- Key finding: Women with gestational diabetes had higher inflammation markers after delivery (20% higher) and right before delivery (12% higher) compared to women without gestational diabetes, even after accounting for age and weight
- What it means for you: Simple blood tests that doctors already do during pregnancy might help identify women with gestational diabetes who have higher inflammation. However, it’s unclear whether these markers actually help predict health problems, so talk to your doctor about what these results mean for your specific situation
The Research Details
This was a retrospective cohort study, meaning researchers looked back at medical records from 366 women who received care at Beijing Friendship Hospital. They divided the women into two groups: those with gestational diabetes controlled through diet (170 women) and those with normal blood sugar (196 women). The researchers collected blood samples at seven different times during pregnancy—starting at 8-12 weeks and continuing through delivery and the postpartum period.
From these blood samples, researchers calculated six different inflammation markers using information from routine blood counts. These markers measure how active the body’s immune and inflammatory systems are. The researchers then compared how these markers changed over time between the two groups, using statistical methods that account for differences in age, weight, and pregnancy history.
The study was designed to see if women with gestational diabetes show different patterns of inflammation throughout pregnancy and after delivery compared to women without gestational diabetes.
This research approach matters because gestational diabetes is common and affects how the body handles blood sugar during pregnancy. Understanding whether gestational diabetes changes inflammation patterns could help doctors identify which women might be at higher risk for complications. The study used blood tests that doctors already perform routinely, making the findings potentially practical for real-world clinical care. By tracking changes over time rather than just looking at one point, the researchers could see how inflammation patterns develop throughout pregnancy.
This study has several strengths: it included a reasonably large sample size (366 women), tracked women at multiple time points throughout pregnancy, and used statistical methods that account for important differences between groups like age and weight. However, the study has limitations: it looked backward at medical records rather than following women forward in time, which means some information might be missing or recorded differently. The study was conducted at a single hospital in Beijing, so results may not apply to all populations. The researchers themselves noted that more research with direct measurements of inflammation is needed to confirm these findings.
What the Results Show
Women with gestational diabetes showed different patterns of inflammation markers throughout pregnancy compared to women without gestational diabetes. The most important finding was that after delivery, women with gestational diabetes had a 20% higher inflammation marker called SIRI (systemic inflammation response index) compared to women without gestational diabetes. This difference remained significant even after researchers adjusted for factors like maternal age, weight, and pregnancy history.
Another key finding involved a marker called PLR (platelet-to-lymphocyte ratio), which was 12% higher in women with gestational diabetes immediately before delivery. This suggests that inflammation patterns may be particularly elevated at specific times during pregnancy and after delivery in women with gestational diabetes.
All six inflammation markers studied showed different patterns over time between the two groups. This means that gestational diabetes appears to affect the body’s inflammatory response in multiple ways, not just one single marker. The differences were most noticeable after delivery and right before delivery, suggesting that these may be critical time windows for inflammation changes.
The study found that women with gestational diabetes were older and had higher body weight at the beginning of pregnancy compared to women without gestational diabetes. These factors were accounted for in the analysis, but they’re important context for understanding the results. The researchers calculated six different inflammation markers from routine blood counts, and all six showed different patterns between groups over time, though not all differences were equally strong at every time point. The most consistent differences appeared in the postpartum period and immediately before delivery.
Previous research has shown that gestational diabetes is associated with increased inflammation, but most studies looked at specific inflammatory markers like C-reactive protein or cytokines. This study is notable because it used routine blood count information that doctors already collect, making it more practical for clinical use. The findings align with existing knowledge that gestational diabetes involves inflammatory changes, but this study provides new information about how these changes develop over the entire pregnancy and postpartum period. The study adds to growing evidence that inflammation may be an important mechanism linking gestational diabetes to health risks.
This study has several important limitations. First, it was retrospective, meaning researchers looked back at existing medical records rather than following women forward in time. This means some information may be incomplete or recorded inconsistently. Second, the study was conducted at a single hospital in Beijing, so results may not apply to other populations or countries with different healthcare practices. Third, the study only measured inflammation markers from routine blood counts, not direct measurements of inflammatory chemicals in the blood. Fourth, the study cannot prove that these inflammation markers actually cause health problems—only that they’re different between groups. Finally, the study did not follow women long-term after pregnancy to see if these inflammation differences predict future health issues.
The Bottom Line
Based on this research, routine blood tests during pregnancy may help identify women with gestational diabetes who have elevated inflammation markers. However, the clinical usefulness of these markers remains unclear. If you have gestational diabetes, discuss with your healthcare provider whether monitoring these inflammation markers is appropriate for your situation. The evidence is moderate—these markers show promise but need more research before they can be recommended as standard clinical tools. Continue following your doctor’s recommendations for managing gestational diabetes through diet and lifestyle, as this remains the primary treatment approach.
This research is most relevant to pregnant women with gestational diabetes, their healthcare providers, and researchers studying pregnancy complications. Women with diet-controlled gestational diabetes should be aware that their inflammation patterns may differ from women without gestational diabetes, particularly after delivery. Healthcare providers may find this information useful for understanding the inflammatory changes associated with gestational diabetes. Women without gestational diabetes or those with other types of diabetes should discuss with their doctors whether these findings apply to their situation.
Changes in inflammation markers appear to develop gradually throughout pregnancy, with the most noticeable differences appearing immediately before delivery and in the postpartum period. If inflammation markers are being monitored, expect to see measurements at multiple time points during pregnancy rather than a single test. The postpartum period (after delivery) appears to be when inflammation differences are most pronounced, so this may be an important time for monitoring if your doctor recommends it.
Frequently Asked Questions
Does gestational diabetes cause inflammation during pregnancy?
Research shows that women with gestational diabetes have higher inflammation markers throughout pregnancy and especially after delivery. A 2026 study of 366 women found postpartum inflammation markers were 20% higher in the gestational diabetes group. However, it’s unclear whether this inflammation causes health problems or is simply a marker of the condition.
Can blood tests predict gestational diabetes complications?
Routine blood count markers show different patterns in women with gestational diabetes, but researchers haven’t yet proven these markers predict complications. The 2026 study found these markers differ between groups but noted that prospective studies with direct inflammatory measurements are needed to establish clinical usefulness.
When are inflammation markers highest in gestational diabetes pregnancy?
According to a 2026 study of 366 pregnant women, inflammation markers were most elevated immediately before delivery and in the postpartum period for women with gestational diabetes. The differences were less pronounced during early and mid-pregnancy but became more noticeable as pregnancy progressed.
Should I ask my doctor about inflammation markers if I have gestational diabetes?
It’s reasonable to discuss with your doctor whether monitoring inflammation markers is appropriate for your care. While research shows these markers differ in gestational diabetes, their clinical usefulness remains unclear. Focus on managing gestational diabetes through diet and lifestyle as recommended by your healthcare provider.
Do inflammation markers change after gestational diabetes delivery?
Yes, research shows inflammation markers remain elevated after delivery in women with gestational diabetes. A 2026 study found the postpartum period had the strongest differences in inflammation markers between women with and without gestational diabetes, suggesting inflammation persists beyond pregnancy.
Want to Apply This Research?
- Track blood test results at each prenatal visit, specifically noting inflammation-related markers from complete blood count results (if your doctor provides them). Record the date, the specific marker values, and any changes from previous tests. This creates a visual record of how your inflammation markers change throughout pregnancy.
- Work with your healthcare provider to maintain consistent diet management of gestational diabetes, as this is the primary treatment. Use the app to log meals, blood sugar readings if monitored, and prenatal appointment dates. Set reminders for scheduled blood tests so you don’t miss the important time windows when inflammation markers are measured.
- Create a timeline in the app marking the seven key time windows mentioned in the study (8-12 weeks, 16-20 weeks, 24-28 weeks, 28-32 weeks, 36 weeks, before delivery, and postpartum). At each visit, record any blood test results your doctor shares. Note any symptoms or changes you experience and correlate them with test dates. Share this information with your healthcare provider to help identify patterns relevant to your care.
This article summarizes research findings and is not medical advice. Gestational diabetes requires individualized medical care from your healthcare provider. Do not use inflammation markers to self-diagnose or self-treat gestational diabetes. If you have gestational diabetes or are pregnant, follow your doctor’s recommendations for monitoring and treatment. The clinical usefulness of the inflammation markers discussed in this study has not been established, and they should not be used as standalone diagnostic or prognostic tools without professional medical guidance. Always consult with your healthcare provider before making any changes to your pregnancy care or gestational diabetes management.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.